WSHA, AHA, 340B Advocacy Groups Urge HHS to Address Drug Manufacturer Activities
September 16, 2020
Opposition is growing to recent efforts of drug manufacturers to restrict drug discounts for 340B hospitals and access to life-saving drugs for patients. ... Read More >>